Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway

Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ -- Optellum and Coreline Soft today...

menu
menu